Chitin and chitosan as tools to combat COVID-19: A triple approach.
Int J Biol Macromol
; 183: 235-244, 2021 Jul 31.
Article
in English
| MEDLINE | ID: covidwho-1208614
ABSTRACT
The progressive and fatal outbreak of the newly emerged coronavirus, SARS-CoV-2, necessitates rigorous collaboration of all health care systems and researchers from all around the world to bring such a devastating pandemic under control. As there is so far no officially approved drug or ideal vaccine for this disease, investigations on this infectious disease are actively pursued. Chitin and chitosan have shown promising results against viral infections. In this review, we first delve into the problematic consequences of viral pandemics followed by an introduction on SARS-CoV-2 taxonomical classification. Then, we elaborate on the immunology of COVID-19. Common antiviral therapies and their related limitations are described and finally, the potential applicability of chitin and chitosan to fight this overwhelming viral pandemic is addressed.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Chitin
/
Chitosan
/
Pandemics
/
SARS-CoV-2
/
COVID-19 Drug Treatment
Type of study:
Observational study
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Int J Biol Macromol
Year:
2021
Document Type:
Article
Affiliation country:
J.ijbiomac.2021.04.157
Similar
MEDLINE
...
LILACS
LIS